This track focuses on the latest innovations in MRI and CT imaging modalities, emphasizing their applications in cancer diagnosis and treatment. Participants will explore the technical advancements that enhance image quality and diagnostic accuracy.

This session will delve into the integration of PET imaging with CT and MRI technologies, highlighting the benefits of hybrid imaging in oncology. Discussions will include comparative analyses of PET/CT and PET/MRI in clinical practice.

This track will examine the role of various biomarkers in the early detection and management of different cancer types, including breast, lung, prostate, and colorectal cancers. Researchers will present findings on the clinical utility of these biomarkers in guiding treatment decisions.

This session will explore the rationale and recent advancements in immunotherapy for cancer treatment, focusing on novel approaches such as T-cell modulation and targeted therapies. Experts will discuss the implications of these therapies on patient outcomes.

This track will investigate the synergistic effects of combining radiotherapy with targeted therapies in cancer treatment. Presentations will cover clinical trials and case studies demonstrating improved efficacy and safety profiles.

This session will highlight the latest advancements in mammographic analysis techniques for breast cancer detection. Participants will discuss the impact of these innovations on screening practices and patient outcomes.

This track will focus on the evolving role of cancer nursing in patient care, emphasizing best practices and innovative approaches to support cancer patients. Discussions will include strategies for enhancing patient education and emotional support.

This session will explore the strategies for targeting the tumor microenvironment in cancer therapy, including the use of bite antibodies and other novel approaches. Researchers will present findings on how these strategies can enhance treatment efficacy.

This track will focus on the clinical applications of cancer biomarkers in treatment planning and monitoring. Experts will discuss the challenges and opportunities in implementing biomarker-driven approaches in oncology.

This session will cover the latest technological advancements in image processing techniques relevant to radiology and oncology. Participants will explore how these innovations improve diagnostic accuracy and treatment planning.

This track will address the ethical implications of advancements in cancer imaging and treatment modalities. Discussions will focus on patient consent, data privacy, and the equitable distribution of emerging therapies.